AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Envista Corp (NVST)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

21.40

-0.36 (-1.65%)

At close: Feb 20, 2025, 3:59 PM

21.45

0.23%

After-hours: Feb 20, 2025, 04:00 PM EST

undefined% (undefined)

Bid	20.87
Market Cap	3.68B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-6.5
PE Ratio (ttm)	-3.29
Forward PE	n/a
Analyst	Hold

Ask	22.5
Volume	980,183
Avg. Volume (20D)	2,280,084.9
Open	21.80
Previous Close	21.76
Day's Range	21.27 - 21.93
52-Week Range	15.14 - 23.06
Beta	undefined

About NVST

Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The company is headquartered in Brea, California and currently employs 12,800 full-time employees. The firm provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The firm operates through two segments: Specialty Products & Technologies, and Equipment & Cons...

[Show more]

Industry Medical - Equipment & Services

Sector Healthcare

IPO Date Sep 18, 2019

Employees 12,300

Stock Exchange NYSE

Ticker Symbol NVST

Website http://www.envistaco.com/

Full Company Profile

Analyst Forecast

According to 13 analyst ratings, the average rating for NVST stock is "Hold." The 12-month stock price forecast is $20.5, which is a decrease of -4.21% from the latest price.

Buy 23.08%

Hold 53.85%

Sell 15.38%

Stock Forecasts

Next Earnings Release

Envista Corp is scheduled to release its earnings on Apr 30, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

2 weeks ago

+5.93%

Envista Holdings shares are trading higher after t... Unlock content with Pro Subscription

3 months ago

+9.05%

Envista Holdings shares are trading higher after Leerink Partners upgraded the stock from Underperform to Market Perform and raised its price target from $16 to $23. Additionally, Baird raised its price target on the stock from $17 to $22.

News

1 week ago · zacks.com

NVST Stock Up on Q4 Earnings and Revenue Beat, Operating Margin Crashes

Envista delivers better-than-expected top and bottom-line results for the fourth quarter of 2024.

2 weeks ago · seekingalpha.com

Envista Holdings Corporation (NVST) Q4 2024 Earnings Call Transcript

Envista Holdings Corporation (NYSE:NVST ) Q4 2024 Earnings Conference Call February 5, 2025 5:30 PM ET Company Participants Jim Gustafson – Vice President-Investor Relations Paul Keel – President and ...

2 weeks ago · zacks.com

Here's What Key Metrics Tell Us About Envista (NVST) Q4 Earnings

While the top- and bottom-line numbers for Envista (NVST) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compar...

2 weeks ago · zacks.com

Envista (NVST) Beats Q4 Earnings and Revenue Estimates

Envista (NVST) came out with quarterly earnings of $0.24 per share, beating the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.29 per share a year ago.

3 weeks ago · zacks.com

Envista (NVST) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Envista (NVST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

4 weeks ago · seekingalpha.com

Envista Is A Margin Improvement Story (Rating Upgrade)

I upgrade Envista stock to a buy due to its potential for increased profitability in 2025. The Implants segment, NVST's largest business unit, is expected to witness positive sales expansion in the co...

1 month ago · zacks.com

Reasons to Retain Envista Stock in Your Portfolio for Now

NVST's strong focus on international market expansion appears promising. Yet, a leveraged balance sheet is worrisome.

1 month ago · zacks.com

Is Envista (NVST) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

1 month ago · zacks.com

NVST or LZAGY: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Medical - Products sector have probably already heard of Envista (NVST) and Lonza Group Ag (LZAGY). But which of these two stocks presents investors with the be...